More than 50 researchers from UW-Madison Alzheimer’s disease research programs joined thousands of global experts at the Alzheimer’s Association International Conference 2025 (AAIC), held July 27-July 31 in Toronto, Canada.
WRAP News
WRAP Info Sessions are back
The 2025 WRAP Info Sessions will be held Sept. 30 to Oct. 14 in multiple locations in Wisconsin: Neenah, Milwaukee, Madison, La Crosse
Two leading dementia researchers join UW–Madison
UW–Madison’s School of Medicine and Public Health is adding Henrik Zetterberg, a Swedish scientist who studies biomarkers, and Hartmuth Kolb, a German-born chemist and expert in imaging technology, to its faculty.
Read all about it: news from our study team in the latest WRAP newsletter
Keeping research participants informed about the study’s findings and work is one of the foundational priorities of the WRAP study. To help with that goal, the study team sends a printed newsletter to participants twice each year.
Dr. Nathaniel Chin discusses UW–Madison role in Alzheimer’s disease blood tests with regional media outlets
Nathaniel Chin, MD, medical director of the WRAP study, appeared on numerous Wisconsin news outlets to discuss the recent Food and Drug Administration (FDA) approval of a blood test for Alzheimer’s disease. The accuracy of the blood test was validated using data samples from the Wisconsin Alzheimer’s Disease Research Center (ADRC) and the Wisconsin Registry for Alzheimer’s Prevention (WRAP).
WRAP research helps launch first FDA-cleared blood test for Alzheimer’s
Data samples used to evaluate the validity of the test are from research conducted at the University of Wisconsin–Madison, including the Wisconsin Registry for Alzheimer’s Prevention.
Thank you, Dr. Langhough
Congratulations to Rebecca Langhough, PhD on her recent retirement.
Dr. Sterling Johnson discusses detection of AD through blood testing on neurology podcast
In the podcast Expert Voices in Dementia, WRAP principal investigator Sterling Johnson, PhD, shares news about detecting Alzheimer’s disease through blood testing and the important implications this research could have on Alzheimer’s disease treatment. Johnson’s lab is investigating the protein p-tau217 as a blood-based biomarker for early detection of Alzheimer’s disease.
Dr. Karly Cody receives de Leon Award
The selected paper, which utilizes Wisconsin ADRC and WRAP participant data, maps a timeline of amyloid and tau accumulation in the brain
Dr. Sterling Johnson addresses impact of potential cuts to NIH funding at news conference
On March 6, Sterling Johnson, PhD, participated in a news conference for the media to discuss the importance of federally funded Alzheimer’s disease research at UW–Madison and its impact on people throughout Wisconsin and nationwide.